Paweł Łaguna

Summary

Affiliation: Katedra i Klinika Pediatrii
Country: Poland

Publications

  1. ncbi Single higher dose of recombinant activated factor VII in the treatment of hemorrhages in patients with hemophilia complicated by inhibitors
    Paweł Łaguna
    Department of Pediatrics Hematology and Oncology, Medical University of Warsaw, Warsaw, Poland
    Adv Clin Exp Med 21:519-24. 2012

Detail Information

Publications1

  1. ncbi Single higher dose of recombinant activated factor VII in the treatment of hemorrhages in patients with hemophilia complicated by inhibitors
    Paweł Łaguna
    Department of Pediatrics Hematology and Oncology, Medical University of Warsaw, Warsaw, Poland
    Adv Clin Exp Med 21:519-24. 2012
    ..Based on present studies, it can be concluded that a single dose of rFVIIa is effective and well tolerated in the treatment of intra-articular bleeds in patients with hemophilia complicated by the presence of inhibitors...